Ambulatory use of blinatumomab in paediatric patients with relapsed or refractory B-cell acute lymphoblastic leukaemia at a single centre in South Africa
Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer, with B-ALL comprising approximately 85% of all cases. Despite a high cure rate, those with refractory disease and/or relapsed (R/R) B-ALL have an inferior overall survival. Blinatumomab, a novel therapy, is a bispecific cluster...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
AOSIS
2026-05-01
|
| Schriftenreihe: | South African Journal of Oncology |
| Schlagworte: | |
| Online-Zugang: | https://sajo.org.za/index.php/sajo/article/view/365 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|